FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377544003: Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2529262017 Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2532641019 Neomycin sulfate+polymyxin b sulfate+prednisolone acetate 0.35%/10000unt/0.5%wv suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3084832018 Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension Is a Product containing neomycin (medicinal product) false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension Is a Compound neomycin preparations false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension Is a Product containing neomycin in topical dosage form false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension Is a Product containing polymyxin B (medicinal product) false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polymyxin B (substance) false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Topical neomycin false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension Is a Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prednisolone acetate false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polymyxin B sulfate false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. anti-infectieux cutané false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin sulfate false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Some
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start